Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Good day everyone and welcome to today’s Avadel Pharmaceuticals ...

Q3 2024 Earnings Call Transcript November 6, 2024 Royalty Pharma plc misses on earnings expectations. Reported EPS is $0.918 ...

Adjusted Net Income Guidance: $1.275 billion to $1.35 billion. Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) reported strong growth across its commercial portfolio, with Xywav and Epidiolex posting ...

My name is Abbie, and I’ll be your operator today. At this time, I would like to welcome everyone to the Jazz Pharmaceuticals Third Quarter 2024 Earnings Call. All lines have been placed on mute ...

Avadel Pharmaceuticals plc (NASDAQ:AVDL) is possibly approaching a major achievement in its business, so we would like to shine some light on the company. Avadel Pharmaceuticals plc operates as a ...

On Monday, Royalty Pharma plc (RPRX) stock saw a modest uptick, ending the day at $27.2 which represents a slight increase of $0.10 or 0.37% from the prior close of $27.1. The stock opened at $27.52 ...

Neimeth International Pharmaceuticals Plc has announced the appointment of Ms. Patricia Aderibigbe and Mr. Adeyemi Odusanya as Independent Non-Executive Directors.

Impax Asset Management Group plc raised its stake in shares of West Pharmaceutical Services, Inc. (NYSE:WST – Free Report) by 56.1% in the third quarter, according to its most recent 13F filing ...

2024 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), a biopharmaceutical company focused on developing breakthrough therapies for blood diseases, is pleased to announce the schedule for the opening of the ...

Good day and thank you for standing by. Welcome to Kiniksa Pharmaceuticals Third Quarter 2024 Earnings Conference Call. At this time all participants are in a listen-only mode. Please be advised ...

DUBLIN, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced that yesterday ...

In this article, we are going to take a look at where Jazz Pharmaceuticals plc (NASDAQ:JAZZ) stands against the other stocks to buy for high returns. The broader market reached new record highs on ...